Financial statements Bioresearch Group
Balance sheet of Bioresearch Group
Company age:
Age:
8 y. 9 m. 23 d.
Share capital:
Share capital:
50 000 PLN
Balance sheet data of BIORESEARCH GROUP
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
|---|---|---|---|---|---|
| Total assets | 1 452 516,85 | 384 512,13 | 2 942 046,17 | 3 629 321,54 | 3 843 584,21 |
| A. Fixed assets | 16 254,50 | 13 003,70 | 9 752,90 | 6 502,10 | 3 251,30 |
| B. Current assets | 1 436 262,35 | 371 508,43 | 2 932 293,27 | 3 639 697,31 | 3 840 332,91 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 1 452 516,85 | 384 512,13 | 2 942 046,17 | 3 629 321,54 | 3 843 584,21 |
| A. Equity | 893 597,73 | 159 972,22 | 1 959 987,37 | 2 887 952,15 | 2 935 736,86 |
| B. Liabilities and provisions for liabilities | 558 919,12 | 224 539,91 | 982 058,80 | 741 369,39 | 907 847,35 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 408 927,82 | 224 539,91 | 273 524,80 | 373 335,63 | 430 860,56 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.